Heart Disease Trial, Recruiting NCT06939751 Sponsor: Inova Health Care Services Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06939751
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older at the time of joining the trial
  • People who have received a heart transplant within the past month (within a window of roughly 2 weeks either side)
  • People whose follow-up care is planned to continue at the transplant centre for at least one year
  • People who are able and willing to attend all required study visits and follow the study procedures

Who may not be able to join:

  • People who received more than one organ transplant at the same time (for example, a heart and kidney together)
  • People who had a previous solid organ transplant (such as a kidney, liver, or lung) before their current heart transplant
  • People who are currently on mechanical heart support devices or whose heart and circulation are not stable (for example, those still needing medications to support blood pressure or heart function)
  • People who currently need kidney dialysis or another form of kidney replacement therapy
  • People who have an active infection that requires a hospital stay, antibiotic or antifungal treatment, or a reduction in their anti-rejection medications
  • People whose body is actively rejecting the transplanted heart and who are being treated with intravenous medications or a blood-filtering procedure called plasmapheresis

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Palak Shah, MD, Inova Schar Heart and Vascular

Phone: (703) 776-8000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Inova Health Care Services
Registry
ClinicalTrials.gov
Start date
28 October 2025
Est. completion
1 January 2031

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Time-to-Event Analysis of Circulating microRNAs (miRs) Predicting Infection in Pediatric Heart Transplant Recipients; Time-to-Event Analysis of Circulating microRNAs (miRs) Predicting Rejection in Pediatric Heart Transplant Recipients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov